What is the catalog number for 4-Methoxycinnamic acid ethyl ester?

The catalog number for 4-Methoxycinnamic acid ethyl ester is HY-N0346.

What sizes are available for 4-Methoxycinnamic acid ethyl ester?

4-Methoxycinnamic acid ethyl ester is available in the following size(s): 1 Each.

Is 4-Methoxycinnamic acid ethyl ester in stock?

4-Methoxycinnamic acid ethyl ester is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures 4-Methoxycinnamic acid ethyl ester?

4-Methoxycinnamic acid ethyl ester is manufactured by QuantiMol.

What is the estimated delivery time for 4-Methoxycinnamic acid ethyl ester?

Estimated delivery time for 4-Methoxycinnamic acid ethyl ester is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for 4-Methoxycinnamic acid ethyl ester?

The safety data sheet for 4-Methoxycinnamic acid ethyl ester is available here: http://file.medchemexpress.com/batch_PDF/HY-N0346/.

4-Methoxycinnamic acid ethyl ester

4-Methoxycinnamic acid ethyl ester (Ethyl p-methoxycinnamate) is an orally active natural compound found. 4-Methoxycinnamic acid ethyl ester exerts anti-inflammatory effects by inhibiting cyclooxygenase (COX-1 (IC50 = 1.12 μM) and COX-2 (IC50 = 0.83 μM) ), NF-κB (IC50 = 88.7 μM) and cytokine production (TNF-α (IC50 = 96.84 μg/mL) and IL-1β (IC50 = 166.4 μg/mL) ) . 4-Methoxycinnamic acid ethyl ester inhibits tumor cell proliferation, migration and cancer metabolism and induces apoptosis.4-Methoxycinnamic acid ethyl ester inhibits VEGF expression, thereby inhibiting angiogenesis. 4-Methoxycinnamic acid ethyl ester has a significant inhibitory effect on dengue virus and Mycobacterium tuberculosis. 4-Methoxycinnamic acid ethyl ester has analgesic effects in rats[1][2][3][4][5][6][7].

Product Specifications

CAS Number

1929-30-2

Product Name Alternative

Ethyl p-methoxycinnamate

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Apoptosis; Bacterial; Caspase; COX; Dengue Virus; Interleukin Related; NF-κB; TNF Receptor; VEGFR

Related Pathways

Anti-infection; Apoptosis; Immunology/Inflammation; NF-κB; Protein Tyrosine Kinase/RTK

Field of Research

Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease

Smiles

O=C(OCC)/C=C/C1=CC=C(OC)C=C1

Molecular Formula

C12H14O3

Molecular Weight

206.24

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Umar MI, et al. Bioactivity-Guided Isolation of Ethyl-p-methoxycinnamate, an Anti-inflammatory Constituent, from Kaempferia galanga L. Extracts. Molecules. 2012 Jul 23;17 (7) :8720-34.|[2]Umar MI, et al. Ethyl-p-methoxycinnamate isolated from Kaempferia galanga inhibits inflammation by suppressing interleukin-1, tumor necrosis factor-α, and angiogenesis by blocking endothelial functions. Clinics (Sao Paulo) . 2014 Feb;69 (2) :134-44.|[3]Lakshmanan D, et al. Ethyl p-methoxycinnamate isolated from a traditional anti-tuberculosis medicinal herb inhibits drug resistant strains of Mycobacterium tuberculosis in vitro. Fitoterapia. 2011 Jun;82 (4) :757-61.|[4]Lallo S, et al. Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFKB from Kaempferia galanga for Melanoma Cells. Life (Basel) . 2022 Mar 24;12 (4) :337.|[5]Tarasuk M, et al. Dual action effects of ethyl-p-methoxycinnamate against dengue virus infection and inflammation via NF-kB pathway suppression. Sci Rep. 2024 Apr 23;14 (1) :9322.|[6]Sasaki Y, et al. Ethyl p-methoxycinnamate inhibits tumor growth by suppressing fatty acid synthesis and depleting ATP. Sci Rep. 2025 May 2;15 (1) :15317.|[7]Umar MI, et al. Cytotoxic and Pro-Apoptotic Properties of Ethyl-p-Methoxycinnamate and Its Hydrophilic Derivative Potassium-p-Methoxycinnamate. Chemistry Africa. 2018 Jul 31;1 (1-2) :87-95.